164 related articles for article (PubMed ID: 21849280)
1. CXCL9 and CXCL10 chemokines as predictors of liver fibrosis in a cohort of primarily African-American injection drug users with chronic hepatitis C.
Zeremski M; Dimova R; Astemborski J; Thomas DL; Talal AH
J Infect Dis; 2011 Sep; 204(6):832-6. PubMed ID: 21849280
[TBL] [Abstract][Full Text] [Related]
2. Peripheral CXCR3-associated chemokines as biomarkers of fibrosis in chronic hepatitis C virus infection.
Zeremski M; Dimova R; Brown Q; Jacobson IM; Markatou M; Talal AH
J Infect Dis; 2009 Dec; 200(11):1774-80. PubMed ID: 19848607
[TBL] [Abstract][Full Text] [Related]
3. [THE ROLE OF CYTOKINES AND CHEMOKINES IN LABORATORY DIAGNOSTIC OF CHRONIC VIRAL HEPATITIS C].
Semenov AV; Arsentieva NA; Lubimova NE; Tulienev SV; Basina VV; Esaulenko EV; Totolyan AA
Klin Lab Diagn; 2015 Aug; 60(8):45-51. PubMed ID: 26596048
[TBL] [Abstract][Full Text] [Related]
4. Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases.
Tacke F; Zimmermann HW; Berres ML; Trautwein C; Wasmuth HE
Liver Int; 2011 Jul; 31(6):840-9. PubMed ID: 21645215
[TBL] [Abstract][Full Text] [Related]
5. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C.
Zeremski M; Petrovic LM; Chiriboga L; Brown QB; Yee HT; Kinkhabwala M; Jacobson IM; Dimova R; Markatou M; Talal AH
Hepatology; 2008 Nov; 48(5):1440-50. PubMed ID: 18798334
[TBL] [Abstract][Full Text] [Related]
6. Study of CXCL9-11 gene polymorphisms in liver fibrosis among patients with chronic hepatitis C.
Magri MC; Alvarez MSM; Iogi AA; Alves GM; Manchiero C; Dantas BP; Prata TVG; Nunes AKDS; Tengan FM
Pathog Dis; 2021 Mar; 79(3):. PubMed ID: 33476381
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels of CXCL11 and CXCL12 are biomarkers of cirrhosis in patients with chronic hepatitis C infection.
Chalin A; Lefevre B; Devisme C; Barget N; Amiot L; Samson M
Cytokine; 2019 May; 117():72-78. PubMed ID: 30826602
[TBL] [Abstract][Full Text] [Related]
8. High MIG (CXCL9) plasma levels favours response to peginterferon and ribavirin in HCV-infected patients regardless of DPP4 activity.
Johansson S; Talloen W; Tuefferd M; Darling J; Fanning G; Fried MW; Aerssens J
Liver Int; 2016 Mar; 36(3):344-52. PubMed ID: 26344576
[TBL] [Abstract][Full Text] [Related]
9. IP-10 can be measured in dried plasma spots in patients with chronic hepatitis C infection.
Ruhwald M; Andersen ES; Christensen PB; Moessner BK; Weis N
PLoS One; 2012; 7(9):e45181. PubMed ID: 23024806
[TBL] [Abstract][Full Text] [Related]
10. Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection.
Berres ML; Trautwein C; Schmeding M; Eurich D; Tacke F; Bahra M; Neuhaus P; Neumann UP; Wasmuth HE
Hepatology; 2011 Feb; 53(2):596-603. PubMed ID: 21274880
[TBL] [Abstract][Full Text] [Related]
11. Progression of liver fibrosis among injection drug users with chronic hepatitis C.
Wilson LE; Torbenson M; Astemborski J; Faruki H; Spoler C; Rai R; Mehta S; Kirk GD; Nelson K; Afdhal N; Thomas DL
Hepatology; 2006 Apr; 43(4):788-95. PubMed ID: 16557548
[TBL] [Abstract][Full Text] [Related]
12. Single nucleotide polymorphisms of CXCL9-11 chemokines are associated with liver fibrosis in HIV/HCV-coinfected patients.
Pineda-Tenor D; Berenguer J; García-Álvarez M; Guzmán-Fulgencio M; Carrero A; Aldámiz-Echevarria T; Tejerina F; Diez C; Jiménez-Sousa MA; Fernández-Rodríguez A; Munoz-Fernandez MA; Resino S
J Acquir Immune Defic Syndr; 2015 Apr; 68(4):386-95. PubMed ID: 25559603
[TBL] [Abstract][Full Text] [Related]
13. Th1 cytokines and chemokines in primary biliary cirrhosis.
Limongi F
Clin Ter; 2015; 166(2):e122-5. PubMed ID: 25945445
[TBL] [Abstract][Full Text] [Related]
14. Antiviral treatment significantly reduces the levels of CXCL9, CXCL10 and CXCL11 in chronic hepatitis C.
Radmanić L; Šimičić P; Bodulić K; Vince A; Zidovec-Lepej S
Cytokine; 2024 Apr; 176():156529. PubMed ID: 38335772
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of chemokine receptor CXCR3 and chemokines IP-10 and MIG in patients with primary biliary cirrhosis and their first degree relatives.
Chuang YH; Lian ZX; Cheng CM; Lan RY; Yang GX; Moritoki Y; Chiang BL; Ansari AA; Tsuneyama K; Coppel RL; Gershwin ME
J Autoimmun; 2005 Sep; 25(2):126-32. PubMed ID: 16243485
[TBL] [Abstract][Full Text] [Related]
16. Interferon-inducible chemokines reflect severity and progression in sarcoidosis.
Su R; Nguyen ML; Agarwal MR; Kirby C; Nguyen CP; Ramstein J; Darnell EP; Gomez AD; Ho M; Woodruff PG; Koth LL
Respir Res; 2013 Nov; 14(1):121. PubMed ID: 24199653
[TBL] [Abstract][Full Text] [Related]
17. Chemokine CXCL10 at week 4 of treatment predicts sustained virological response in patients with chronic hepatitis C.
Kurelac I; Lepej SZ; Grlgic I; Gorenec L; Papic N; Dusek D; Barsic B; Vince A
J Interferon Cytokine Res; 2012 Aug; 32(8):386-91. PubMed ID: 22799464
[TBL] [Abstract][Full Text] [Related]
18. The combination of CXCL9, CXCL10 and CXCL11 levels during primary HIV infection predicts HIV disease progression.
Yin X; Wang Z; Wu T; Ma M; Zhang Z; Chu Z; Hu Q; Ding H; Han X; Xu J; Shang H; Jiang Y
J Transl Med; 2019 Dec; 17(1):417. PubMed ID: 31836011
[TBL] [Abstract][Full Text] [Related]
19. Serum IFN-γ-inducible chemokines CXCL9 and CXCL10 are elevated in non-immediate drug hypersensitivity reactions.
Wang F; Cai R; He D; Zhao Y; Ye Y; Zhang X
Asian Pac J Allergy Immunol; 2016 Sep; 34(3):236-241. PubMed ID: 27001652
[TBL] [Abstract][Full Text] [Related]
20. CXCL9, CXCL10, and CXCL11; biomarkers of pulmonary inflammation associated with autoimmunity in patients with collagen vascular diseases-associated interstitial lung disease and interstitial pneumonia with autoimmune features.
Kameda M; Otsuka M; Chiba H; Kuronuma K; Hasegawa T; Takahashi H; Takahashi H
PLoS One; 2020; 15(11):e0241719. PubMed ID: 33137121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
